Tislelizumab in People With Colorectal Cancer

NCT06529523 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Tislelizumab

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]